Li Lab,MD: Clinical Trials

3 trials sponsored by Li Lab,MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Not yet recruiting 1
Phase 12Not yet recruiting 1, Recruiting 1

Follow Li Lab,MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-Plant-Protein-Diet or High-Animal-Protein-Diet for Improving Alcoholic Fatty Liver Disease
whey protein powder, soy protein powder - Alcohol-associated Fatty Liver Disease
Phase 1 / Phase 2RecruitingLi Lab,MD742026-10-102026-10-27
High-Protein Diet for Improving Alcoholic Fatty Liver Disease
high protein diet, control diet, perilla peptide dietary group - Alcohol-associated Fatty Liver Disease
Phase 1 / Phase 2Not yet recruitingLi Lab,MD742026-07-012026-06-29
Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial
Combination of cynara scolymus, silybum marianum, curcuma longa, and glycyrrhiza glabra, Placebo maltodextrin - Metabolic-associated Fatty Liver Disease (MAFLD)
Phase 2RecruitingLi Lab,MD1002025-03-012025-04-23

Interventions

Diet, High-Protein (1)  ·  Glycyrrhiza glabra extract (1)  ·  milk-thistle extract (1)  ·  turmeric extract (1)

Countries

China (2)

Top investigators

Songtao Li (3)  ·  Rennan Ren (1)

Results publications

PMID 20216558, PMID 27765690, PMID 31338545, PMID 31652512, PMID 32652799, PMID 35571881, PMID 36082508, PMID 36508737, PMID 38299591, PMID 38674860, PMID 38879879